A method of detecting the presence or absence of a sealant applied to a textile graft includes the steps of: providing a textile graft having a first surface and an opposed second surface; providing a water soluble masking agent; applying the water soluble masking agent to at least a portion of the first surface of the textile graft; providing a sealant solution; providing a visual indicator; applying the water insoluble sealing agent and the visual indicator to the second surface of the textile graft; and removing the water soluble masking agent after the step of applying sealing solution. The second surface has visual indication of the visual indicator and the first surface is substantially free of visual indication of the visual indicator. An implantable textile graft includes the selectively applied visual indicator.

A method of detecting the presence or absence of a sealant applied to a textile graft includes the steps of: providing a textile graft having a first surface and an opposed second surface; providing a water soluble masking agent; applying the water soluble masking agent to at least a portion of the first surface of the textile graft; providing a sealant solution; providing a visual indicator; applying the water insoluble sealing agent and the visual indicator to the second surface of the textile graft; and removing the water soluble masking agent after the step of applying sealing solution. The second surface has visual indication of the visual indicator and the first surface is substantially free of visual indication of the visual indicator. An implantable textile graft includes the selectively applied visual indicator.

Embodiments of the present disclosure encompass systems and methods for in-situ/in vivo, bottom-up tissue generation for wound repair, repair of tissue defects, and the like. Embodiments of the systems of the present disclosure include modular scaffolds seeded with cells (modular tissue forming units (MTFUs)) for packing a tissue defect, such that these MTFUs are able to fill the wound bed with cells of one or more needed tissue types supported by the modular scaffolding particles.

The present disclosure relates to compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of preparing compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of using the bone compositions, bone implants and variants thereof.

The present disclosure relates to compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of preparing compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of using the bone compositions, bone implants and variants thereof.

According to the present invention, there are provided a chamber for transplantation which has a high durability, and in which an enclosed biological constituent can be maintained for a long period of time because an interior space thereof is efficiently secured; and a method for manufacturing the chamber for transplantation. The chamber for transplantation includes one or more membranes for immunoisolation at a boundary between an inside and an outside of the chamber for transplantation, in which all of the membranes for immunoisolation include a porous membrane containing a polymer, and a joint portion at which the porous membranes are directly fusion welded to each other is provided. The method for manufacturing a chamber for transplantation includes preparing one or more porous membranes containing a polymer selected from polysulfone and polyethersulfone, bringing one part of the porous membrane into direct contact with another part of the porous membrane, and performing a heat fusion welding of the two parts that are in direct contact with each other at a temperature which is a glass transition temperature of the polymer or higher and lower than a melting point of the polymer.

A porous biocomposite material including a polymer matrix having pores defined by several surfaces and collagen on the surface of the pores and the outer surfaces of the polymer matrix, the ratio, by weight, collagen to polymer matrix is from 20:80 to 40:60. The polymer matrix of the porous biocomposite material includes a copolymer which is prepared from a poly(ε-caprolactone) diol, a poly(lactide-co-glycolide) diol and a lysine diisocyanate (LDI). Also included are an implant which is a biodegradable, porous foam and with similar biomechanics to the normal meniscus, with tensile, compressive and tear strength, and preventing the pores from collapsing under condyle-tibia pressure. It serves as a scaffold for damaged meniscus repair or replacement, indicated for grade 3 or 4 terminal knee arthrosis, for the prevention of treatment, by cartilage regeneration, of advanced knee arthrosis, to avoid knee prostheses in young patients.

A porous biocomposite material including a polymer matrix having pores defined by several surfaces and collagen on the surface of the pores and the outer surfaces of the polymer matrix, the ratio, by weight, collagen to polymer matrix is from 20:80 to 40:60. The polymer matrix of the porous biocomposite material includes a copolymer which is prepared from a poly(ε-caprolactone) diol, a poly(lactide-co-glycolide) diol and a lysine diisocyanate (LDI). Also included are an implant which is a biodegradable, porous foam and with similar biomechanics to the normal meniscus, with tensile, compressive and tear strength, and preventing the pores from collapsing under condyle-tibia pressure. It serves as a scaffold for damaged meniscus repair or replacement, indicated for grade 3 or 4 terminal knee arthrosis, for the prevention of treatment, by cartilage regeneration, of advanced knee arthrosis, to avoid knee prostheses in young patients.

Disclosed herein is a hybrid polymeric material comprising a tropoelastin and a copolymer of a polyol monomer and a polycarboxylic acid monomer. The hybrid polymeric material is suitable for use as a tissue scaffold.

Disclosed herein is a hybrid polymeric material comprising a tropoelastin and a copolymer of a polyol monomer and a polycarboxylic acid monomer. The hybrid polymeric material is suitable for use as a tissue scaffold.